Can transcatheter PDA closure be performed in neonates ≤1000 grams? The Memphis experience.


Journal

Congenital heart disease
ISSN: 1747-0803
Titre abrégé: Congenit Heart Dis
Pays: United States
ID NLM: 101256510

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 03 09 2018
accepted: 16 10 2018
entrez: 28 2 2019
pubmed: 28 2 2019
medline: 14 5 2019
Statut: ppublish

Résumé

Advancements in transcatheter technology have now made it possible to safely close patent ductus arteriosus (PDA) in extremely low birth weight (ELBW) infants. The objective of this article is to describe our technique for transcatheter PDA closure (TCPC) in ELBW infants. The techniques employed are very specific to this population and are drastically different when compared to the procedure performed in patients weighing >5 kg. A multidisciplinary team approach should be taken to evaluate and manage ELBW infants in order to achieve success. It is important that specific techniques with venous-only approach outlined in this article be followed to achieve optimal results with low risk of complications. To date, in Memphis, 55 ELBW infants have had successful TCPC at a weight of ≤1000 g with minimal procedure-related complications. It is important that specific techniques with venous-only approach outlined in this article be followed to achieve optimal results with low risk of complications. This procedure entails a steep learning curve and should be limited to specialized centers with expertise in these thanscatheter procedures. There has been 100% procedural success of performing TCPC in children ≤1000 g. There have been only two procedure-related complications which happened to the first two patients, ≤1000 g, that we performed TCPC on. It is feasible and probably safe to perform TCPC in children ≤1000 g. The techniques described in this article represent our institutional experience and have helped us improve clinical outcomes in ELBW infants.

Identifiants

pubmed: 30811793
doi: 10.1111/chd.12700
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-84

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Shyam Sathanandam (S)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

Hitesh Agrawal (H)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

Sandeep Chilakala (S)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

Jason Johnson (J)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

Kimberly Allen (K)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

Christopher Knott-Craig (C)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

B Rush Waller (B)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

Ranjit Philip (R)

University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tennessee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH